Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection - Poll - MDSpire

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection

  • By

  • Laura Marcos-Villar

  • Beatriz Perdiguero

  • Laura Sin

  • Enrique Álvarez

  • Sara Flores

  • José M. Casasnovas

  • Tirso Pons

  • Carlos Oscar S. Sorzano

  • Daniel del Hoyo

  • Philipp Lapuhs

  • María J. Alonso

  • Mariano Esteban

  • Carmen Elena Gómez

  • May 5, 2026

  • 0 min

Share

Original Source(s)

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection

  • by Laura Marcos-Villar, Beatriz Perdiguero, Laura Sin, Enrique Álvarez, Sara Flores, José M. Casasnovas, Tirso Pons, Carlos Oscar S. Sorzano, Daniel del Hoyo, Philipp Lapuhs, María J. Alonso, Mariano Esteban, Carmen Elena Gómez

  • May 5, 2026

Related Content

COVID-19, Vaccines, and Retinal Vascular Disease

A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.

Ebola at the World Cup? Here’s what we should actually worry about

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update